Caki-1 (人肾透明细胞癌皮肤转移细胞) (STR鉴定正确)

参考文献

• Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55(2020/12/01)

  作者：Jiafu Feng, Yongcan Guo, Yuanmeng Li

  期刊：Journal Of Experimental & Clinical Cancer Research

  DOI：10.1186/s13046-020-01744-2

  影响因子 ：11.300

  引用产品：CL-0010 CL-0052 CL-0254 CL-0326

• Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming(2023/02/20)

  作者：Zhangnan Liu, Mengzhen Fan, Junqing Hou

  期刊：Cell Death & Disease

  DOI：10.1038/s41419-023-05677-4

  影响因子 ：9.000

  引用产品：CL-0010 CL-0021 CL-0052 CL-0254

• Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma(2023/08/26)

  作者：Yuwei Zhang, Wei Guo, Yangkun Feng

  期刊：Computational and Structural Biotechnology Journal

  DOI：10.1016/j.csbj.2023.08.023

  影响因子 ：6.000

  引用产品：CL-0010 CL-0052 CL-0109 CL-0254

• LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p(2019/11/21)

  作者：Zhuo Ye, Jiachen Duan, Lihui Wang

  期刊：Cancer Cell International

  DOI：10.1186/s12935-019-1008-6

  影响因子 ：5.800

  引用产品：CL-0052

• LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p(2019/11/21)

  作者：Zhuo Ye, Jiachen Duan, Lihui Wang

  期刊：Cancer Cell International

  DOI：10.1186/s12935-019-1008-6

  影响因子 ：5.800

  引用产品：CL-0005 CL-0009 CL-0010 CL-0052 PM150110 PM150210 PM150710

• Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.(2022/09/21)

  作者：Longfei Yang, Yuwei Zhang, Yang Wang

  期刊：Frontiers in Pharmacology

  DOI：10.3389/fphar.2022.938134

  影响因子 ：5.600

  引用产品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910

• Tumor Cell-Derived Exosomal circ-PRKCI Promotes Proliferation of Renal Cell Carcinoma via Regulating miR-545-3p/CCND1 Axis(2022/12/25)

  作者：Yiguan Qian, Yang Li, Luwei Xu

  期刊：Cancers

  DOI：10.3390/cancers15010123

  影响因子 ：5.200

  引用产品：CL-0009 CL-0010 CL-0021 CL-0052 CL-0109

• LncRNA-encoded Micropeptide ACLY‍-‍BP drives lipid deposition and cell proliferation in Clear Cell Renal Cell Carcinoma via maintenance of ACLY acetylation(2023/07/06)

  作者：Shenghua Zhang, Zheng Zhang, Xiaolong Liu

  期刊：MOLECULAR CANCER RESEARCH

  DOI：10.1158/1541-7786.MCR-22-0781

  影响因子 ：5.200

  引用产品：CL-0005 CL-0010 CL-0021 CL-0052

• Spindle pole body component 24 homolog potentiates tumor progression via regulation of SRY-box transcription factor 2 in clear cell renal cell carcinoma(2022/01/14)

  作者：Chengfang Sun, Jingchao Wei, Zhilin Long

  期刊：Faseb Journal

  DOI：10.1096/fj.202101310R

  影响因子 ：4.800

  引用产品：CL-0052 CL-0177

• Identification of the regulatory mechanism of ACE2 in COVID-19–induced kidney damage with systems genetics approach(2023/03/23)

  作者：Xueling Yang, Chunhua Lin, Jian Liu

  期刊：JOURNAL OF MOLECULAR MEDICINE-JMM

  DOI：10.1007/s00109-023-02304-9

  影响因子 ：4.700

  引用产品：CL-0052

• A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance(2023/04/08)

  作者：Longfei Yang, Yuwei Zhang, Yifan Tang

  期刊：Scientific Reports

  DOI：10.1038/s41598-023-27975-9

  影响因子 ：4.600

  引用产品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910

• Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma(20220/2/16)

  作者：Yiguan Qian, Yang Li, Ke Chen

  期刊：Journal of Inflammation Research

  DOI：10.2147/JIR.S347732

  影响因子 ：4.500

  引用产品：CL-0009 CL-0010 CL-0021 CL-0052 CL-0109

• HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma(2021/2/19)

  作者：Yuanbo Cui, Chunyan Zhang, Ya Li

  期刊：Cell Biology International

  DOI：10.1002/cbin.11568

  影响因子 ：3.900

  引用产品：CL-0010 CL-0052 CL-0109 CL-0254

• The potential of Lycium barbarum miR166a in kidney cancer treatment(2022/12/28)

  作者：Qiang Zhang, Zhiyuan Xie, Yan Li

  期刊：EXPERIMENTAL CELL RESEARCH

  DOI：10.1016/j.yexcr.2022.113455

  影响因子 ：3.700

  引用产品：CL-0021 CL-0052 PM150210 PM150710

• Comprehensive analysis of the HOXA gene family identifes HOXA13as a novel oncogenic gene in kidney renal clear cell carcinoma(2020/05/22)

  作者：Yuanbo Cui, Ming Yan, Chunyan Zhang

  期刊：JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

  DOI：10.1007/s00432-020-03259-x

  影响因子 ：3.600

  引用产品：CL-0010 CL-0052 CL-0109 CL-0254

• P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway(2023/01/02)

  作者：Zhechuan Zhang, Yuanfeng Zhang, Ronggui Zhang

  期刊：MEDICAL ONCOLOGY

  DOI：10.1007/s12032-022-01926-2

  影响因子 ：3.400

  引用产品：CL-0009 CL-0010 CL-0021 CL-0052

• Sertraline/ICG‐loaded liposome for dual‐modality imaging and effective chemo‐photothermal combination therapy against metastatic clear cell renal cell carcinoma(2020/1/14)

  作者：Yuting Lei, Li Zeng, Shuqing Xie

  期刊：Chemical Biology & Drug Design

  DOI：10.1111/cbdd.13652

  影响因子 ：3.000

  引用产品：CL-0052

• RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma(2023/10/12)

  作者：Jing Ma, Shaofei He, Mingyang Li

  期刊：PATHOLOGY RESEARCH AND PRACTICE

  DOI：10.1016/j.prp.2023.154886

  影响因子 ：2.800

  引用产品：CL-0052

• TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression(2023/10/30)

  作者：Lingling Xie, Yu Fang, Jianping Chen

  期刊：PeerJ

  DOI：10.7717/peerj.16316

  影响因子 ：2.700

  引用产品：CL-0052

点击展开收起列表